A mass spectrometry-based analysis performed by the Clinical Proteomic Tumor Analysis Consortium group using fresh frozen materials from 122 TCGA breast cancer specimens reported DNA-dependent protein kinase catalytic subunit (DNA-PKcs) to be the most specific biomarker for the basal-like subtype12,13. The gene discussed is PRKDC; the disease is breast carcinoma.